Stay updated on Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.

Latest updates to the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedMajor update to the page content: a government-operating status notice and a new version tag (v3.2.0) replacing v3.1.0; no changes to pricing or availability information.SummaryDifference1%
- Check21 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1; a 'Back to Top' link was removed. This reflects a version update with a small navigation change.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has been updated to include new facility names and locations, specifically adding details for various cities in Belgium, Germany, the Netherlands, and South Korea, as well as information about the drug Risankizumab. The revision number has also been updated to v3.0.0.SummaryDifference4%
- Check65 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
Stay in the know with updates to Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.